ARTICLE | Company News
Synaptic GPCR deal with PG
July 10, 2002 7:00 AM UTC
SNAP licensed to Procter & Gamble (PG) exclusive rights to two SNAP alpha-2 adrenergic receptor compounds in preclinical testing. The indications of the products are undisclosed, but SNAP did say that...